| Cash flow (USD) | FY 2025 ended Dec 31, 2025 | FY 2024 ended Dec 31, 2024 | FY 2024 ended Dec 31, 2023 | FY 2024 ended Dec 31, 2022 |
|---|---|---|---|---|
| Net income | 189.11M | 20.52M | -154.60M | -53.91M |
| Depreciation and amortization | 164.28M | 204.48M | 202.34M | 203.97M |
| Stock-based compensation | 70.10M | 69.17M | 3.92M | 3.55M |
| Cash from operations | 490.17M | 23.77M | 210.78M | -4.65M |
| Capital expenditure | -95.48M | -80.91M | -73.53M | -70.11M |
| Free cash flow | 394.69M | -57.14M | 137.26M | -74.77M |
| Acquisitions | -204.56M | -59.80M | -63.06M | -42.46M |
| Cash from investing | -305.08M | -140.24M | -134.43M | 45.36M |
| Share buybacks | -43.17M | -650.0K | -650.0K | |
| Net debt issued | -50.27M | -830.33M | -30.44M | -40.72M |
| Cash from financing | -157.87M | 164.65M | -76.91M | -73.81M |
| Net change in cash | 27.22M | 48.18M | -557.0K | -33.11M |
From BrightSpring Health Services, Inc.'s 10-K and 10-Q filings with the SEC. Fiscal years are the company's own, so they may not match the calendar. A blank cell means the company did not report that line. New to this? Read cash flow or reading a 10-K.
Revenue, earnings, margins and balance sheet trends drawn by TradingView from its own data, so figures can differ slightly from the SEC table above.